Stankovich Thomas's Form 4 filing
Vyome Holdings, Inc (HIND) · filed Jul 6, 2023
- Accession no.
- 0001235802-23-000075
- Filed
- Jul 6, 2023
- Trade date
- Mar 31-Jun 30, 2023
- Filing delay
- 97 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $26.9K. Open-market sales total $746.14. It was filed 97 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stankovich ThomasCIK 0001181166 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | Common Stock, $0.001 par value per share | SSaleDisposed | −109 | $2.60 | −$283.4 | 5,982 | Direct | |
| Apr 30, 2023 | Common Stock, $0.001 par value per share | SSaleDisposed | −96 | $2.36 | −$226.56 | 5,886 | Direct | |
| May 31, 2023 | Common Stock, $0.001 par value per share | SSaleDisposed | −98 | $2.41 | −$236.18 | 5,788 | Direct | |
| Jun 30, 2023 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +17,702 | $1.52F2 | +$26,907.04 | 23,490 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.54, inclusive. The reporting person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Referenced by the price of 1 transaction in Table I.